May 16, 2023 / 02:00PM GMT
Luca Issi - RBC Capital Markets, Research Division - Research Analyst
Luca Issi, senior biotech analyst here at RBC Capital Markets. And today is a great privilege to have Ionis with a fireside chat. Representing the company, we have Brett Monia, Chief Executive Officer.
Brett, thanks so much for joining us. How are you doing today?
Brett P. Monia - Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
I'm doing great. Thanks, Luca. It's really, really great to be here, and thanks for the opportunity.
Questions and Answers:
Luca Issi - RBC Capital Markets, Research Division - Research AnalystFantastic. We have a long list of questions here, but maybe before I ask you about the individual programs, can you just talk big picture about what progress has the organization made over the last few months? And maybe most importantly, what's ahead here for Ionis?
Brett P. Monia - Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
Sure. Happy to. So I think
Trustpilot
